189-hESC Dopamine Progenitors for Parkinson's Disease

The article details a Phase 1/2a clinical trial evaluating the safety and exploratory effectiveness of transplanting human embryonic stem cell (hESC)-derived dopaminergic progenitors (A9-DPC) in patients with Parkinson’s disease (PD). Researchers generated highly pure dopaminergic progenitors and bilaterally transplanted them into the putamen of twelve patients across low and high-dose groups. The...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动